.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
RNA Interference
Paul H. Johnson
€ 159.46
FREE Delivery in Ireland
Description for RNA Interference
Hardcover. RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development provides a general overview of this rapidly emerging field, with a strong emphasis on issues and aspects that are important to a drug development team. Editor(s): Johnson, Paul H. Num Pages: 328 pages, Illustrations. BIC Classification: PN; PSAK1. Category: (P) Professional & Vocational. Dimension: 243 x 160 x 24. Weight in Grams: 646.
RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development provides a general overview of this rapidly emerging field, with a strong emphasis on issues and aspects that are important to a drug development team. The first part covers more general background of RNA interference and its application in drug discovery. In the second part, the book addresses siRNA (small interfering RNA), a pharmaceutically potent form, and its use and delivery in therapeutics along with manufacturing and delivery aspects.
RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development provides a general overview of this rapidly emerging field, with a strong emphasis on issues and aspects that are important to a drug development team. The first part covers more general background of RNA interference and its application in drug discovery. In the second part, the book addresses siRNA (small interfering RNA), a pharmaceutically potent form, and its use and delivery in therapeutics along with manufacturing and delivery aspects.
Product Details
Format
Hardback
Publication date
2011
Publisher
John Wiley and Sons Ltd United Kingdom
Number of pages
328
Condition
New
Number of Pages
340
Place of Publication
New York, United States
ISBN
9780471771517
SKU
V9780471771517
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
About Paul H. Johnson
PAUL H. JOHNSON, PhD, is a cofounder and Chief Scientific Officer at PhaseRx, Inc. He is the author of numerous scientific papers and patents, and was the recipient of the 2007 Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery.
Reviews for RNA Interference
"This is an accessible book that approaches the goal of therapeutic RNAi delivery from a technological viewpoint. Chapter organization and figure presentation allow for interrupted reading without disrupting the flow. Cell and molecular biologists will find both interesting details and practical methods to improve the preclinical applicability of a research project. While therapeutic RNAi is still largely in the development ... Read more